ELMWOOD PARK, N.J., June 1, 2015 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for second quarter 2015 before the open of market trading on Monday, June 8th, 2015. The Company's earnings conference call is to take place the same day at 10:30 a.m. EDT. The call will be hosted by Marc D. Grodman M.D., President and Chief Executive Officer.
The live webcast will be available at the Company's corporate Web site, www.bioreference.com, under Investor Relations, and through www.streetevents.com. To listen to the live call please go to the Web site ten minutes before the conference call is scheduled to begin. You will need to register as well as download and install any necessary audio software. The Webcast will be archived, on both Web sites, for 30 days following the call.
About BioReference Laboratories, Inc.
BioReference Laboratories is one of the largest and fastest growing full service diagnostic laboratories in the world, providing clinical testing services to physician offices, clinics, hospitals, long term care facilities and employers while also advancing drug discovery and development with disease foundations, academic and pharmaceutical partners. Our comprehensive testing capabilities and expertise spans molecular diagnostics, anatomical pathology, women's health, oncology and rare disease genetics. BioReference, and our subsidiaries, have an international presence in more than 50 countries.
Statements included in this release that are not historical in nature, are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will" or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of Bio-Reference Laboratories, Inc. and its subsidiaries. Statements looking forward in time are included in this release pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date they are made and which reflect management's current estimates, projections, expectations or beliefs and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include, but are not limited to, the risks and uncertainties detailed from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to publicly update or review any forward-looking information, whether as a result of new information, future developments or otherwise.
CONTACT: Tara Mackay Investor Relations Coordinator (201) 791-2600 (201) 791-1941 (fax) firstname.lastname@example.org
Source:Bio-Reference Laboratories, Inc.